null

SMILES: CN1CCC(CC1)Oc1ccc(\C=C\c2n[nH]c3cc(ccc23)[C@@H]2C[C@@]22C(=O)Nc3ccccc23)cc1

InChI Key: InChIKey=QQQHEKKJXCPXAX-SPGBXREFSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 6 hits for monomerid = 50073552   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Serine/threonine-protein kinase PLK4 (Homo sapiens (Human))	BDBM50073552 (CHEMBL3408956 | US10358436, Example A78 | US990780...) Show SMILES CN1CCC(CC1)Oc1ccc(\C=C\c2n[nH]c3cc(ccc23)[C@@H]2C[C@@]22C(=O)Nc3ccccc23)cc1 |r| Show InChI InChI=1S/C31H30N4O2/c1-35-16-14-23(15-17-35)37-22-10-6-20(7-11-22)8-13-27-24-12-9-21(18-29(24)34-33-27)26-19-31(26)25-4-2-3-5-28(25)32-30(31)36/h2-13,18,23,26H,14-17,19H2,1H3,(H,32,36)(H,33,34)/b13-8+/t26-,31-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	PubMed	n/a	n/a	1.10	n/a	n/a	n/a	n/a	n/a	n/a
TBA Curated by ChEMBL					Assay Description Inhibition of PLK4 (unknown origin) by ELISA				J Med Chem 58: 147-69 (2015) BindingDB Entry DOI: 10.7270/Q2M0475V
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase PLK4 (Homo sapiens (Human))	BDBM50073552 (CHEMBL3408956 | US10358436, Example A78 | US990780...) Show SMILES CN1CCC(CC1)Oc1ccc(\C=C\c2n[nH]c3cc(ccc23)[C@@H]2C[C@@]22C(=O)Nc3ccccc23)cc1 |r| Show InChI InChI=1S/C31H30N4O2/c1-35-16-14-23(15-17-35)37-22-10-6-20(7-11-22)8-13-27-24-12-9-21(18-29(24)34-33-27)26-19-31(26)25-4-2-3-5-28(25)32-30(31)36/h2-13,18,23,26H,14-17,19H2,1H3,(H,32,36)(H,33,34)/b13-8+/t26-,31-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
The Scripps Research Institute					Assay Description PLK4 activity was measured using an indirect ELISA detection system. Dephosphorylated GST-PLK4 (4 nM) was incubated in the presence of 15 μM ATP...				J Med Chem 50: 3359-68 (2007) BindingDB Entry DOI: 10.7270/Q2KD216W
					More data for this Ligand-Target Pair
Aurora kinase B (Homo sapiens (Human))	BDBM50073552 (CHEMBL3408956 | US10358436, Example A78 | US990780...) Show SMILES CN1CCC(CC1)Oc1ccc(\C=C\c2n[nH]c3cc(ccc23)[C@@H]2C[C@@]22C(=O)Nc3ccccc23)cc1 |r| Show InChI InChI=1S/C31H30N4O2/c1-35-16-14-23(15-17-35)37-22-10-6-20(7-11-22)8-13-27-24-12-9-21(18-29(24)34-33-27)26-19-31(26)25-4-2-3-5-28(25)32-30(31)36/h2-13,18,23,26H,14-17,19H2,1H3,(H,32,36)(H,33,34)/b13-8+/t26-,31-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
University Health Network US Patent					Assay Description Aurora B inhibition was determined using the Z-Lyte assay kit from Invitrogen. The assay was performed using the recommended manufacturer's instr...				US Patent US10358436 (2019) BindingDB Entry DOI: 10.7270/Q2K939WH
					More data for this Ligand-Target Pair
Serine/threonine-protein kinase PLK4 [1-391] (Homo sapiens (Human))	BDBM50073552 (CHEMBL3408956 | US10358436, Example A78 | US990780...) Show SMILES CN1CCC(CC1)Oc1ccc(\C=C\c2n[nH]c3cc(ccc23)[C@@H]2C[C@@]22C(=O)Nc3ccccc23)cc1 |r| Show InChI InChI=1S/C31H30N4O2/c1-35-16-14-23(15-17-35)37-22-10-6-20(7-11-22)8-13-27-24-12-9-21(18-29(24)34-33-27)26-19-31(26)25-4-2-3-5-28(25)32-30(31)36/h2-13,18,23,26H,14-17,19H2,1H3,(H,32,36)(H,33,34)/b13-8+/t26-,31-/m0/s1	PDB UniProtKB/SwissProt GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
University Health Network US Patent					Assay Description Active PLK4 was purified from an E. coli expression system as an amino terminal GST fusion of residues 1-391 of human PLK4. The protein was purified ...				US Patent US10358436 (2019) BindingDB Entry DOI: 10.7270/Q2K939WH
					More data for this Ligand-Target Pair
Aurora kinase A (Homo sapiens (Human))	BDBM50073552 (CHEMBL3408956 | US10358436, Example A78 | US990780...) Show SMILES CN1CCC(CC1)Oc1ccc(\C=C\c2n[nH]c3cc(ccc23)[C@@H]2C[C@@]22C(=O)Nc3ccccc23)cc1 |r| Show InChI InChI=1S/C31H30N4O2/c1-35-16-14-23(15-17-35)37-22-10-6-20(7-11-22)8-13-27-24-12-9-21(18-29(24)34-33-27)26-19-31(26)25-4-2-3-5-28(25)32-30(31)36/h2-13,18,23,26H,14-17,19H2,1H3,(H,32,36)(H,33,34)/b13-8+/t26-,31-/m0/s1	PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<500	n/a	n/a	n/a	n/a	n/a	n/a
University Health Network US Patent					Assay Description Aurora A inhibition was determined using the Z-Lyte assay kit from Invitrogen. The assay was performed using the recommended manufacturer's instr...				US Patent US10358436 (2019) BindingDB Entry DOI: 10.7270/Q2K939WH
					More data for this Ligand-Target Pair
Aurora kinase B (Homo sapiens (Human))	BDBM50073552 (CHEMBL3408956 | US10358436, Example A78 | US990780...) Show SMILES CN1CCC(CC1)Oc1ccc(\C=C\c2n[nH]c3cc(ccc23)[C@@H]2C[C@@]22C(=O)Nc3ccccc23)cc1 |r| Show InChI InChI=1S/C31H30N4O2/c1-35-16-14-23(15-17-35)37-22-10-6-20(7-11-22)8-13-27-24-12-9-21(18-29(24)34-33-27)26-19-31(26)25-4-2-3-5-28(25)32-30(31)36/h2-13,18,23,26H,14-17,19H2,1H3,(H,32,36)(H,33,34)/b13-8+/t26-,31-/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	US Patent	n/a	n/a	<100	n/a	n/a	n/a	n/a	n/a	n/a
The Scripps Research Institute					Assay Description Aurora B inhibition was determined using the Z-Lyte assay kit from Invitrogen. The assay was performed using the recommended manufacturer's instr...				J Med Chem 50: 3359-68 (2007) BindingDB Entry DOI: 10.7270/Q2KD216W
					More data for this Ligand-Target Pair